Trince
Asse · Founded 2021
About Trince
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.7M
- Last round: Undisclosed (Jan 2026)
- Website: https://trincebio.com/
Industries & Categories
Biopharma, Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/trince-1992 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.